{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:16:46Z","timestamp":1790954206480,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.humpath.2022.12.015","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T19:30:48Z","timestamp":1672428648000},"page":"124-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["TSC\/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-3175","authenticated-orcid":false,"given":"Melissa Y.","family":"Tjota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankhuri","family":"Wanjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Antic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.12.015_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.12.015_bib2","first-page":"279","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2022.12.015_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health organization classification of tumours of the urinary system and male genital organs\u2014Part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.12.015_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"Renal cell carcinoma with leiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib5","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00428-008-0697-3","article-title":"Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity","volume":"454","author":"Michal","year":"2009","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/adpa.2000.17890","article-title":"Benign renal angiomyoadenomatous tumor: a previously unreported renal tumor","volume":"4","author":"Michal","year":"2000","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00428-009-0788-9","article-title":"Difference between RAT and clear cell papillary renal cell carcinoma\/clear renal cell carcinoma","volume":"454","author":"Michal","year":"2009","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays","volume":"19","author":"Kadri","year":"2017","journal-title":"J Mol Diagn JMD"},{"key":"10.1016\/j.humpath.2022.12.015_bib12","first-page":"1167","article-title":"Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2022.12.015_bib13","first-page":"1392","article-title":"New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2022.12.015_bib14","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.humpath.2022.12.015_bib15","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.mayocp.2020.11.004","article-title":"Renal neoplasia in tuberous sclerosis: a study of 41 patients","volume":"96","author":"Gupta","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2022.12.015_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification","volume":"12","author":"Siadat","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2022.12.015_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2017.11.013","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex","volume":"75","author":"Williamson","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib18","first-page":"240","article-title":"Molecular aspects of renal cell carcinoma: a review","volume":"1","author":"Koul","year":"2010","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.humpath.2022.12.015_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","article-title":"Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study","volume":"44","author":"Tjota","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.humpath.2020.12.006","article-title":"TSC\/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+\/CK20-\/vimentin-: a validation study","volume":"115","author":"Tjota","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anndiagpath.2015.11.003","article-title":"Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review","volume":"21","author":"Hes","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.12.015_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.eururo.2020.09.027","article-title":"The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: implications in diagnosis and management","volume":"79","author":"Weng","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.12.015_bib23","first-page":"1207","article-title":"Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins","volume":"24","author":"Rohan","year":"2011","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2022.12.015_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2022.09.001","article-title":"Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma","volume":"129","author":"Gupta","year":"2022","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:05Z","timestamp":1758645665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":24,"alternative-id":["S0046817722002945"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.015","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TSC\/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}